LOX and breast cancer: In an elegant series of experiments, Erler and colleagues identified a role for LOX in breast cancer cells, showing that by reducing the activity of this molecule (by either chemical inhibition or RNAi) lung metastases could be greatly decreased, and liver metastases eliminated in mice bearing orthotopic MDA-MB-231 tumors [16].